GRBK Earnings

GRBK reported its FY2025Q4 earnings on 2026-02-25, showcasing a revenue of 0.00 against an estimate of 469.00M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 1.62 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following GRBK's FY2025Q4 earnings announcement on 2026-02-25, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, GRBK's stock price tends to shift by an average of +0.28% in the 10 days leading up to earnings and +2.78% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate GRBK’s annual revenue to reach 471.00M, while the EPS is projected at 2.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 1.58% and EPS estimates Revise Upward by 7.13% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between GRBK's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 1.58%, while EPS estimates moved Revise Upward by 7.13% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, GRBK's stock price typically moves by +0.28% in the 10 days before its earnings and +2.78% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 2.00 and revenue of 471.00M.

The earnings call reveals several negative indicators: declining average sales prices, reduced backlog value, and increased incentives due to affordability challenges. The Q&A highlights management's reluctance to provide margin guidance and ongoing reliance on incentives to drive sales. Despite operational efficiencies and strategic expansion plans, the financial performance, including a 15% decrease in net income and a 20% backlog decline, suggests a negative sentiment. Given the company's market cap of approximately $2.56 billion, these factors are likely to result in a stock price decline between -2% to -8% over the next two weeks.